Stockchecker on skin care
FDA Approves Recombinant Chikungunya Vaccine, Vimkunya
The vaccine is the first virus-like particle single-dose vaccine for chikungunya for patients 12 years and older.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves MenABCWY Vaccine for Patients Ages 10 to 25 Years
The combination includes 2 previously approved vaccines to target the 5 major serogroups of Neisseria meningitidis.
FDA Grants Fast Track Designation to Cannabis Withdrawal Syndrome Therapy
A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.
FDA Approves Risdiplam Tablet for Spinal Muscular Atrophy
The tablet formation of risdiplam (Evrysdi) demonstrates bioequivalence to the oral formulation of the drug.
FDA Grants Fast Track Designation to Amlenetug As Treatment for Multiple System Atrophy
The designation is based on the AMULET phase 2 trial, which was the first-in-human study of the drug.